Thatcher Sloan

Affordability in drug pricing can be addressed by bringing the manufacturer and plan sponsor to negotiate costs and determine fair compensation for product and service providers in the supply chain.

There seems to be a growing divergence of messages in the marketplace on how the pharmacy benefit is valued.